Log in to your Inderes Free account to see all free content on this page.

Coloplast

585.20 DKK

+1.14 %

Less than 1K followers

COLO B

NASDAQ Copenhagen

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Investor consensus

+1.14 %

+0.45 %

-5.15 %

-6.90 %

-25.57 %

-34.22 %

-32.86 %

-35.32 %

+1,147.76 %

Coloplast is a developer of products and services adapted for people with different medical conditions. The company's product portfolio consists of various care equipment and is mainly used in the areas of ostomy, incontinence, urology, and skin and wound care. Today, the company operates in a global market through its own sales channels. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Market cap

133.54B DKK

Turnover

126.67M DKK

Revenue

EBIT %

P/E

Dividend yield-%

Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

5.12.

2025

Half year dividend

6.2.

2026

Interim report Q1'26

12.5.

2026

Interim report Q2'26

All

Press releases

ShowingAll content types

Regulatory press release10 hours ago

Coloplast A/S - Decisions at the Annual General Meeting 2025

Regulatory press release11/11/2025, 9:12 AM

Coloplast A/S - Notice of Annual General Meeting 2025

Regulatory press release11/4/2025, 6:32 AM

Coloplast A/S - Annual Report 2024/25 & Remuneration Report 2024/25

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release11/4/2025, 6:31 AM

Coloplast A/S - Full-Year Financial Results 2024/25

Press release10/20/2025, 8:03 AM

Coloplast A/S - FY 2024/25 Earnings Release - Invitation for conference call on 4 Nov 2025 at 11.00 CET

Regulatory press release10/9/2025, 3:52 PM

Coloplast interim CEO Lars Rasmussen will step down from the Board at the upcoming Annual General Meeting

Regulatory press release9/30/2025, 12:39 PM

Coloplast A/S - Financial Calendar 2025-26

Press release9/2/2025, 6:06 AM

Coloplast A/S - Coloplast presents new 5-year strategy, Impact4

Regulatory press release9/2/2025, 5:59 AM

Coloplast A/S - Announcement no. 07/2025 - Coloplast announces new financial ambition towards 2030

Press release8/19/2025, 1:44 PM

Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025

Regulatory press release8/19/2025, 5:33 AM

Coloplast A/S - Interim Financial Report, 9M 2024/25

Regulatory press release8/19/2025, 5:30 AM

Coloplast A/S - Announcement no. 05/2025 - Coloplast announces changes to Executive Leadership Team

Press release8/8/2025, 7:35 AM

Coloplast A/S - 9M 2024/25 Earnings Release - Invitation to conference call on 19 August 2025 at 11.00am CEST

Press release6/3/2025, 10:57 AM

Coloplast A/S - Invitation to Coloplast's Capital Markets Day on 2 September 2025

Regulatory press release5/8/2025, 12:42 PM

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

Regulatory press release5/6/2025, 5:29 AM

Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25

Regulatory press release5/5/2025, 3:11 PM

Coloplast A/S CEO Kristian Villumsen steps down as of today

Regulatory press release5/1/2025, 10:23 AM

Coloplast A/S Revised guidance for FY 2024/25

Press release4/15/2025, 12:04 PM

Coloplast A/S - H1 2024/25 Earnings Release - Invitation to conference call on 6 May 2025 at 11.00am CEST

Regulatory press release2/4/2025, 12:12 PM

Coloplast A/S - Allocation of Share Options

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.